Copy
EuropaBio Newsletter 10-14 February
HEADLINES
New Worldwide Studies Find Significant Benefits From Biotech Crops: GMO cultivation up 15 percent in Europe

This week, two independent reports published by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA) and the International Food Policy Research Institute (IFPRI) confirmed the positive benefits plant biotechnology has on farmers worldwide.Read more

The curious case of the EU's GMO authorisation system: Opinion Piece by EuropaBio Secretary General Nathalie Moll in Euractiv 
Policy makers generally trust the scientific recommendations of independent EU agencies. But in the GMO area, a vicious circle of lack of approvals and decreased trust in the technology is being perpetuated, leading to a negative precedent of “politics over science”, writes Nathalie Moll.Read more

EuropaBio and Smithers Rapra announce call for papers for European Forum for Industrial Biotechnology and the Biobased economy 2014
In its 7th year, EFIB is clearly established as the market leading conference for the biobased economy. Participants are now welcome to submit their papers covering new products or processes. This years, EFIB will be heading to Reims, from 30 September - 2 October 2014.Read more  


Exclusive: The miracle cure - scientists turn human skin into stem cells >
A simple laboratory process raises hopes of a cure for serious illnesses including heart disease and Parkinson's, and could lead to the creation of embryos. Learn more about how turning skin into stem cells will has to potential to revolutionise the biotech sector.Read more  

Healthcare Biotech

Fixing a body’s broken genes is becoming possible

Learn how scietists have magaged to turn fiction into facts.  Using gene therapy to treat disease is at last looking as if it may become science fact.Read more 
 

New drug candidates from genome sequence

Scientists have developed a potentially general approach to design drugs from genome sequence.To prove it, they identified a highly potent compound that causes cancer cells to attack themselves and die.Read more 
 

Cancer Treatment Developed From Curry Compound Could Revolutionize Cancer Research

  An experimental treatment for cancer that is based off of a curry compound known as curcumin is continuing to gain ground as a possible cancer-fighting agent. Find out how this simple remedy can have such a huge impact for cancer patients.Read more 

Agricultural Biotech

GM food policy: Trade disruptions from zero thresholds may cause 'severe' economic woes

The European Union (EU) zero threshold policy for unapproved GM crops and foods could lead to 'severe' economic problems if it ever leads to a disruption in trade with major exporting countries, warn researchers.Read more 
 

: International Food Policy Research Institute (IFPRA): Report about the role of agricultural technologies in a world of food and resource scarcity

Climate change, population, and income growth will drive food demand in the coming decades. The report examines which current and potential strategies offer solutions to fight hunger and feed the world’s growing population which is expected to reach 9 billion by 2050.Read more 

Industrial Biotech

Rabobank predicts increased European bioplastic production

According to a report published by the Netherlands-based Rabobank,  the European demand for bioplastics show the highest growth projections. Find out here what are the key projections highlighting the future of industrial biotechnology.Read more  

 

EVENTS

  • 27-28 February: Annual Conference on EU Law in the Pharmaceutical sector, Brussels, Belgium More information
     
  • 10-11 March: The Innovation Convention, Brussels, Belgium. More information
  • 05-06 June: BIOVISION, Lyon, France. More information
     
  • 09-10 July: 3rd European Biorefinery Traning School , Budapest, Hungary. More information
     
  • 13-17 July, 16th European Congress on Biotechnology, Edinburgh, Scotland.More information
  • 02-03 December,BioFIT 2014, Lille, France.More information
Copyright © 2014 EuropaBio, All rights reserved.